相关实验视频

Updated: Jun 3, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

通过细胞外囊泡介导的微RNA重编程瘤微环境来增强瘤性病毒疗法

Victoria A Jennings¹, Reah Rumbold-Hall¹, Gemma Migneco¹

¹Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.

Frontiers in immunology

|January 7, 2025

概括

用microRNA武装的瘤病毒重新编程免疫抑制性卵巢癌细胞,增强抗瘤免疫力. 这种方法有效地将治疗性microRNAs传递给与瘤相关的巨细胞,改善免疫治疗结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
病毒学病毒学

背景情况:

卵巢癌 (OvCa) 免疫疗法由于免疫抑制瘤微环境 (TME) 面临挑战.
在TME内的瘤相关巨细胞 (TAMs) 促进瘤进展和免疫逃避.
微RNAs (miRNAs) 影响TAM可塑性,为治疗干预提供了一个目标.

研究的目的:

研究瘤学病毒 (OV) 作为免疫调节miRNAs到OvCa.TAMs的输送载体的潜力.
评估miRNA武装OVs在逆转TAM前瘤功能和增强抗瘤免疫力的有效性.

主要方法:

小RNA测序确定了TAMs中差异表达的miRNAs.
精选的miRNAs (miR-155,miR-19a) 被克隆成瘤性拉布多病毒 (ORV).
在体外和体内OvCa模型被用于评估ORV疗效,TDEV产生和TAM重编程.

主要成果:

ORV感染增加了瘤衍生的细胞外囊泡 (TDEV) 的产生,这些细胞被骨髓状细胞优先吸收,包括TAMs.
通过TDEVs传递的miRNAs逆转了TAM免疫抑制活性,并增强了T细胞的增殖.
在患有卵巢瘤的小鼠中,ORV-miR-19a显著改善了生存率.

结论:

用免疫调节miRNA武装ORV是一种可行的策略,可以准TME中的髓状细胞.
输送的miRNAs可以重编程TAM,逆转它们的前瘤性质,并提高癌症免疫疗法的疗效.

关键词:

抗瘤免疫力抗瘤免疫力这是一个小RNARNA.科性病毒病毒.与瘤相关的巨细胞.瘤微环境是一个微环境.

更多相关视频

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...